The NIDHC Summit touted breakthroughs, but the real story in **technology** and **innovation** is who controls the pipeline.
The narrative of 'science accelerated' masks a dangerous consolidation of power. Unpacking the true winners and losers in today's breakneck scientific progress.
Dr. Anita Bandrowski's APE Award signals a seismic shift in **scholarly communication** and **research integrity**. But who really benefits from this push for **transparency**?
The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.
The recent US patent for TrialAssure's date offset technology reveals a deeper struggle over clinical trial data integrity and ownership.
Five years after its breakthrough, the true cost of AlphaFold's AI revolution in **protein folding** is emerging. It's not just about science.
AI is boosting neuroprotective drug trials for stroke, but who truly profits from this precision medicine revolution? The real battle is over data ownership.
DP Technology's massive Series C signals a chilling trend: the consolidation of scientific data, not just the acceleration of breakthroughs.
Five years after its debut, the true impact of AlphaFold isn't just about biology; it's about the centralization of scientific power in AI.
Direct exoplanet imaging is the next frontier, but the real race isn't for life; it's for orbital real estate and technological supremacy.
Forget collaboration. The new wave of Quantum AI alliances signals a dangerous geopolitical race, not a shared future. Analyze the hidden power grab.
A new report confirms China is exploiting US-funded nuclear research. This isn't just intellectual property theft; it's a strategic pivot in global energy dominance.